XML 21 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Balance (in shares) at Dec. 31, 2015   32,509,000      
Balance at Dec. 31, 2015 $ 1,543,780 $ 325 $ 1,440,321 $ (7,594) $ 110,728
Net income (loss) 85,071       85,071
Other comprehensive loss (5,445)     (5,445)  
Exercise of stock options (in shares)   29,000      
Exercise of stock options 3,303 $ 0 3,303    
Restricted stock grants (in shares)   195,000      
Restricted stock grants 0 $ 2 (2)    
Restricted stock grants surrendered (in shares)   (142,000)      
Restricted stock grants surrendered (16,424) $ (1) (16,423)    
Stock compensation expense, net of forfeitures 36,388   36,388    
Employee stock purchase plan (in shares)   15,000      
Employee stock purchase plan 2,842 $ 0 2,842    
Excess tax benefit from stock-based compensation 4,698   4,698    
Balance (in shares) at Dec. 31, 2016   32,606,000      
Balance at Dec. 31, 2016 1,654,213 $ 326 1,471,127 (13,039) 195,799
Net income (loss) 122,695       122,695
Other comprehensive loss 4,019     4,019  
Exercise of stock options (in shares)   82,000      
Exercise of stock options 6,797 $ 1 6,796    
Restricted stock grants (in shares)   187,000      
Restricted stock grants 0 $ 2      
Restricted stock grants adjustments     (2)    
Restricted stock grants surrendered (in shares)   (99,000)      
Restricted stock grants surrendered (14,902) $ (1) (14,901)    
Stock compensation expense, net of forfeitures 38,921   38,921    
Stock issued for equity offering (in shares)   3,317,000      
Stock issued for equity offering 833,911 $ 33 833,878    
Employee stock purchase plan (in shares)   14,000      
Employee stock purchase plan 3,434 $ 0 3,434    
Balance (in shares) at Dec. 31, 2017   36,107,000      
Balance at Dec. 31, 2017 2,651,250 $ 361 2,339,253 (9,020) 320,656
Balance at January 1, 2018 2,705,714 $ 361 2,339,253 (9,020) 375,120
Net income (loss) 238,334       238,334
Other comprehensive loss (2,668)     (2,668)  
Exercise of stock options (in shares)   177,000      
Exercise of stock options 21,993 $ 2 21,991    
Restricted stock grants (in shares)   160,000      
Restricted stock grants 0 $ 1 (1)    
Restricted stock grants surrendered (in shares)   (116,000)      
Restricted stock grants surrendered (24,327) $ (1) (24,326)    
Stock compensation expense, net of forfeitures 40,889   40,889    
Employee stock purchase plan (in shares)   15,000      
Employee stock purchase plan 5,641 $ 0 5,641    
Stock issued for acquisitions (in shares)   103,000      
Stock issued for acquisitions 36,366 $ 1 36,365    
Balance (in shares) at Dec. 31, 2018   36,446,000      
Balance at Dec. 31, 2018 $ 3,021,942 $ 364 $ 2,419,812 $ (11,688) $ 613,454